Suche senden
Hochladen
Galactoarabinan
•
0 gefällt mir
•
5 views
Creative Biolabs
Folgen
Galactoarabinan https://www.creative-biolabs.com/glycoprotein/galactoarabinan-202.htm
Weniger lesen
Mehr lesen
Technologie
Melden
Teilen
Melden
Teilen
1 von 1
Jetzt herunterladen
Downloaden Sie, um offline zu lesen
Empfohlen
Recently, the development of molecular biotechnology allows modifications of viral genomes genetically and optimizes the transformation of available viruses with weak pathogenicity. These methods are used to enhance the oncolytic effect and reduce adverse reactions to maximize both efficacy and safety. Indeed, the oncolytic virus can stimulate a pro-inflammatory tumor environment by enhancing antigen recognition and robust immune responses. It overcomes the immune evasiveness and escape of malignant cells to eliminate the tumor cells. https://www.creative-biolabs.com/oncolytic-virus/definition-of-an-oncolytic-virus.htm
What is oncolytic virus
What is oncolytic virus
Creative Biolabs
An oncolytic virus is a form of promising therapeutic tool for the treatment of malignant tumors, which uses viruses to selectively infect and kill tumor cells and further to induce or boost specific antitumor immunity. https://www.creative-biolabs.com/oncolytic-virus/definition-of-an-oncolytic-virus.htm
What is oncolytic virus therapy
What is oncolytic virus therapy
Creative Biolabs
Oncolytic viruses encoding reporter genes utilized for in vivo molecular imaging are useful to locate the distribution of oncolytic viruses in pre-clinical tests. Optical detection methods mainly include green fluorescent protein (GFP), enhanced GFP (eGFP), discosoma red fluorescent protein (DsRed), and bioluminescence imaging (BLI), which utilizes luciferases. Reporter-encoding oncolytic viruses, including vaccinia virus, adenovirus, herpes simplex virus and vesicular stomatitis virus, allow accurate tracking of gene expression, tumor metastases, viral infection as well as assessment of gene therapy. https://www.creative-biolabs.com/oncolytic-virus/category-reporter-encoding-oncolytic-virus-293.htm
Reporter-encoding Oncolytic Virus
Reporter-encoding Oncolytic Virus
Creative Biolabs
Vaccinia virus can accommodate more than 30 kb of foreign DNA. Foreign genes can be stably integrated into the viral genome, resulting in efficient and long-term gene expression. The deletion of the viral genes of thymidine kinase (TK) and vaccinia growth factors (VGF) results in enhanced tumor-selectively and antitumor activity, and reduced virus virulence. https://www.creative-biolabs.com/oncolytic-virus/category-pre-made-oncolytic-vaccinia-virus-291.htm
Pre-made Oncolytic VACV
Pre-made Oncolytic VACV
Creative Biolabs
Oncolytic viruses are a class of antitumor agents that selectively kill tumor cells without affecting normal cells. Vaccinia virus (VACV) is a large, enveloped virus that is considered as the most potential live biotherapeutic agent because of its strong oncolytic efficacy and potent antigen presentation capability that can combine well with its natural oncolytic activities for cancer immunotherapy. Many types of modified vaccinia virus have been used for in vitro and in vivo studies, as well as clinical trials.https://www.creative-biolabs.com/oncolytic-virus/category-pre-made-oncolytic-vaccinia-virus-291.htm
Pre-made Oncolytic Vaccinia Virus
Pre-made Oncolytic Vaccinia Virus
Creative Biolabs
Partial deletion of the HSV gene results in superior packaging capacity of >30 kb foreign DNA with low toxicity as an expression vector. Multiple modified purified oncolytic herpes simplex virus (oHSV) products can avoid evading the host immune response and reduce toxicity by gene knock-out, such as ICP0, ICP4, ICP22, ICP27 or ICP47.https://www.creative-biolabs.com/oncolytic-virus/category-pre-made-oncolytic-herpes-simplex-virus-290.htm
Pre-made Oncolytic HSV
Pre-made Oncolytic HSV
Creative Biolabs
Oncolytic viruses are using for the treatment of cancer due to the specific antitumor activity in tumor cells. Herpes simplex virus (HSV) is a human neurogenic dsDNA virus that has the characteristic of life-long latent infection of neurons and allows for long-term transgene expression.https://www.creative-biolabs.com/oncolytic-virus/category-pre-made-oncolytic-herpes-simplex-virus-290.htm
Pre-made Oncolytic Herpes Simplex Virus
Pre-made Oncolytic Herpes Simplex Virus
Creative Biolabs
Oncolytic viruses have the potential to powerfully and selectively kill cancer cells and have shown impressive efficacy in preclinical and clinical settings. However, their potential can be restricted by inefficient delivery into the complex tumor environment. Thus, the efficient delivery of oncolytic viruses remains a significant challenge in the field of oncology, limiting their therapeutic effect. https://www.creative-biolabs.com/oncolytic-virus/approaches-to-delivery-of-oncolytic-viruses.htm
Oncolytic Virus Delivery
Oncolytic Virus Delivery
Creative Biolabs
Empfohlen
Recently, the development of molecular biotechnology allows modifications of viral genomes genetically and optimizes the transformation of available viruses with weak pathogenicity. These methods are used to enhance the oncolytic effect and reduce adverse reactions to maximize both efficacy and safety. Indeed, the oncolytic virus can stimulate a pro-inflammatory tumor environment by enhancing antigen recognition and robust immune responses. It overcomes the immune evasiveness and escape of malignant cells to eliminate the tumor cells. https://www.creative-biolabs.com/oncolytic-virus/definition-of-an-oncolytic-virus.htm
What is oncolytic virus
What is oncolytic virus
Creative Biolabs
An oncolytic virus is a form of promising therapeutic tool for the treatment of malignant tumors, which uses viruses to selectively infect and kill tumor cells and further to induce or boost specific antitumor immunity. https://www.creative-biolabs.com/oncolytic-virus/definition-of-an-oncolytic-virus.htm
What is oncolytic virus therapy
What is oncolytic virus therapy
Creative Biolabs
Oncolytic viruses encoding reporter genes utilized for in vivo molecular imaging are useful to locate the distribution of oncolytic viruses in pre-clinical tests. Optical detection methods mainly include green fluorescent protein (GFP), enhanced GFP (eGFP), discosoma red fluorescent protein (DsRed), and bioluminescence imaging (BLI), which utilizes luciferases. Reporter-encoding oncolytic viruses, including vaccinia virus, adenovirus, herpes simplex virus and vesicular stomatitis virus, allow accurate tracking of gene expression, tumor metastases, viral infection as well as assessment of gene therapy. https://www.creative-biolabs.com/oncolytic-virus/category-reporter-encoding-oncolytic-virus-293.htm
Reporter-encoding Oncolytic Virus
Reporter-encoding Oncolytic Virus
Creative Biolabs
Vaccinia virus can accommodate more than 30 kb of foreign DNA. Foreign genes can be stably integrated into the viral genome, resulting in efficient and long-term gene expression. The deletion of the viral genes of thymidine kinase (TK) and vaccinia growth factors (VGF) results in enhanced tumor-selectively and antitumor activity, and reduced virus virulence. https://www.creative-biolabs.com/oncolytic-virus/category-pre-made-oncolytic-vaccinia-virus-291.htm
Pre-made Oncolytic VACV
Pre-made Oncolytic VACV
Creative Biolabs
Oncolytic viruses are a class of antitumor agents that selectively kill tumor cells without affecting normal cells. Vaccinia virus (VACV) is a large, enveloped virus that is considered as the most potential live biotherapeutic agent because of its strong oncolytic efficacy and potent antigen presentation capability that can combine well with its natural oncolytic activities for cancer immunotherapy. Many types of modified vaccinia virus have been used for in vitro and in vivo studies, as well as clinical trials.https://www.creative-biolabs.com/oncolytic-virus/category-pre-made-oncolytic-vaccinia-virus-291.htm
Pre-made Oncolytic Vaccinia Virus
Pre-made Oncolytic Vaccinia Virus
Creative Biolabs
Partial deletion of the HSV gene results in superior packaging capacity of >30 kb foreign DNA with low toxicity as an expression vector. Multiple modified purified oncolytic herpes simplex virus (oHSV) products can avoid evading the host immune response and reduce toxicity by gene knock-out, such as ICP0, ICP4, ICP22, ICP27 or ICP47.https://www.creative-biolabs.com/oncolytic-virus/category-pre-made-oncolytic-herpes-simplex-virus-290.htm
Pre-made Oncolytic HSV
Pre-made Oncolytic HSV
Creative Biolabs
Oncolytic viruses are using for the treatment of cancer due to the specific antitumor activity in tumor cells. Herpes simplex virus (HSV) is a human neurogenic dsDNA virus that has the characteristic of life-long latent infection of neurons and allows for long-term transgene expression.https://www.creative-biolabs.com/oncolytic-virus/category-pre-made-oncolytic-herpes-simplex-virus-290.htm
Pre-made Oncolytic Herpes Simplex Virus
Pre-made Oncolytic Herpes Simplex Virus
Creative Biolabs
Oncolytic viruses have the potential to powerfully and selectively kill cancer cells and have shown impressive efficacy in preclinical and clinical settings. However, their potential can be restricted by inefficient delivery into the complex tumor environment. Thus, the efficient delivery of oncolytic viruses remains a significant challenge in the field of oncology, limiting their therapeutic effect. https://www.creative-biolabs.com/oncolytic-virus/approaches-to-delivery-of-oncolytic-viruses.htm
Oncolytic Virus Delivery
Oncolytic Virus Delivery
Creative Biolabs
Numerous viruses are being developed pre-clinically and clinically. An investigation of all registered clinical trials in 2017 demonstrates 78 interventional trials regarding OVs. This ability for near-universal therapeutic impact in cancer makes OVs a popular therapeutic tool. Today, both preclinical and early-stage clinical trials are intensively investigating the approach to improve oncolytic virotherapy. https://www.creative-biolabs.com/oncolytic-virus/applications-of-oncolytic-viruses-in-cancer-treatment.htm
Oncolytic Virus Application
Oncolytic Virus Application
Creative Biolabs
To fully optimize oncolytic virotherapy and provide meaningful mechanistic insight, it is important to have representative animal models of oncolysis in various tumor types. https://www.creative-biolabs.com/oncolytic-virus/animal-models-for-oncolytic-virus-study.htm
Oncolytic Virus Animal Model
Oncolytic Virus Animal Model
Creative Biolabs
Abciximab (also known as abcixifiban or c7E3 Fab), is the Fab fragment of the chimeric human-murine, monoclonal antibody 7E3. It is composed of murine variable regions and human constant regions.https://www.creativebiolabs.net/abciximab-overview.htm
Abciximab mechanism of action
Abciximab mechanism of action
Creative Biolabs
Abagovomab is a murine monoclonal anti-idiotypic antibody (MW: 165-175 kDa), produced by a mouse hybridoma and generated against OC125, which serves to functionally imitate the human cancer antigen 125 (CA-125). https://www.creativebiolabs.net/abagovomab-overview.htm
Abagovomab mechanism of action
Abagovomab mechanism of action
Creative Biolabs
Wnt comprises a diverse family of secreted lipid-modified signaling glycoproteins that are 350-400 amino acids in length. Wnt is an acronym in the field of genetics that stands for 'Wingless/Integrated'.https://www.creativebiolabs.net/wnt-signaling-pathway.htm
Wnt Pathway
Wnt Pathway
Creative Biolabs
TNF works through two receptors, TNFR1 and TNFR2. TNFR1 is the major signal receptor of TNF-α. TNFR2, which mediates limited biological responses, binds to TNF-α and TNF-β. TNF signaling transduction through TNFR1 and TNFR2 can induce a variety of cellular responses, which depends on many factors, including the metabolic state of the cell and the adaptor proteins present in the cell.https://www.creativebiolabs.net/tnf-signaling-pathway.htm
TNF Pathway
TNF Pathway
Creative Biolabs
Innate immune receptors, also known as pattern recognition receptors (PRRs), have been identified in the serum, on the cell surface, in endosomes, and in the cytoplasm. Toll-like receptors (TLRs) is one of the particularly important groups of PRRs.https://www.creativebiolabs.net/tlr-signal-pathway.htm
TLR Pathway
TLR Pathway
Creative Biolabs
Transforming growth factor beta (TGF-β) is a cytokine that participates in both physiological and pathological processes.https://www.creativebiolabs.net/tgf-beta-signaling-pathway.htm
TGF-β Pathway
TGF-β Pathway
Creative Biolabs
T-cell receptor (TCR) is a heterodimers composed of α and β peptide chains. TCR is mainly responsible for recognizing the antigens presented by major histocompatibility complex (MHC) molecules on the surface of antigen presenting cells (APC).https://www.creativebiolabs.net/tcr-signal-pathway.htm
TCR Pathway
TCR Pathway
Creative Biolabs
Ras, which is a low-molecular-weight GDP/GTP-binding guanine triphosphatase, is the prototypical member of the Ras superfamily of proteins. https://www.creativebiolabs.net/ras-signaling-pathway.htm
RAS Pathway
RAS Pathway
Creative Biolabs
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors, which are responsible for regulating gene expression.https://www.creativebiolabs.net/ppar-signaling-pathway.htm
PPAR Pathway
PPAR Pathway
Creative Biolabs
PI3K-Akt signaling pathway is one of the important signal transduction pathways in cells. It is involved in regulating cell metabolism, growth, proliferation, survival, transcription and protein synthesis by affecting the activation of downstream effector molecules. https://www.creativebiolabs.net/pi3k-akt-signaling-pathway.htm
VPI3K-AKT Pathway
VPI3K-AKT Pathway
Creative Biolabs
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD19. https://www.creativebiolabs.net/anti-cd19-adcc-enhanced-antibody-taplitumomab-105903.htm
Afuco™ Anti-CD19 ADCC Recombinant Antibody (Taplitumomab), ADCC Enhanced
Afuco™ Anti-CD19 ADCC Recombinant Antibody (Taplitumomab), ADCC Enhanced
Creative Biolabs
Recombinant chimeric antibody expressed in CHO binding to human CAIX. Girentuximab is a chimeric monoclonal antibody designed for the treatment of renal cell carcinoma. https://www.creativebiolabs.net/Anti-CAIX-CA9-Therapeutic-Antibody-Rencarex-13758.htm
Anti-CAIX/CA9 Recombinant Antibody
Anti-CAIX/CA9 Recombinant Antibody
Creative Biolabs
Recombinant mouse monoclonal antibody expressed in CHO binding to human B-lymphoma cell. Detumomab is a mouse monoclonal antibody developed for the treatment of cancer. https://www.creativebiolabs.net/Anti-B-cell-lymphomas-Therapeutic-Antibody-detumomab-326.htm
Anti-B Cell Lymphomas Recombinant Antibody
Anti-B Cell Lymphomas Recombinant Antibody
Creative Biolabs
Recombinant monoclonal antibody to P. aeruginosa. Panobacumab (proposed INN) is a monoclonal antibody designed as an antibacterial against P. aeruginosa. It is a fully human pentameric IgM antibody with a mouse J chain. https://www.creativebiolabs.net/Anti-B-anthracis-anthrax-protective-antigen-PA-Therapeutic-Antibody-Aerumab-11-13641.htm
Anti-B. anthracis anthrax protective antigen
Anti-B. anthracis anthrax protective antigen
Creative Biolabs
Recombinant monoclonal antibody to Bacillus anthracis protective antigen. Raxibacumab is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax. Its efficacy has been proven in rabbits and monkeys. https://www.creativebiolabs.net/Anti-B-anthracis-anthrax-protective-antigen-PA-Therapeutic-Antibody-ABthrax-13697.htm
Anti-B. Anthracis Anthrax Protective Antigen (Raxibacumab)
Anti-B. Anthracis Anthrax Protective Antigen (Raxibacumab)
Creative Biolabs
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human AFP. Tacatuzumab is a humanized monoclonal antibody intended for the treatment of cancer. https://www.creativebiolabs.net/anti-afp-adcc-enhanced-antibody-tacatuzumab-105879.htm
Afuco™ Anti-AFP ADCC Recombinant Antibody (Tacatuzumab), ADCC Enhanced
Afuco™ Anti-AFP ADCC Recombinant Antibody (Tacatuzumab), ADCC Enhanced
Creative Biolabs
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD22. https://www.creativebiolabs.net/anti-cd22-adcc-enhanced-antibody-inotuzumab-105908.htm
Afuco™ Anti-CD22 ADCC Recombinant Antibody (Inotuzumab), ADCC Enhanced
Afuco™ Anti-CD22 ADCC Recombinant Antibody (Inotuzumab), ADCC Enhanced
Creative Biolabs
Recombinant monoclonal antibody to MMP9. Andecaliximab is a human monoclonal antibody that can be potentially used in the treatment of Crohn's disease (CD), Colitis, ulcerative (UC), Solid tumors. https://www.creativebiolabs.net/Andecaliximab-67638.htm
Anti-Human MMP9 Recombinant Antibody
Anti-Human MMP9 Recombinant Antibody
Creative Biolabs
Weitere ähnliche Inhalte
Mehr von Creative Biolabs
Numerous viruses are being developed pre-clinically and clinically. An investigation of all registered clinical trials in 2017 demonstrates 78 interventional trials regarding OVs. This ability for near-universal therapeutic impact in cancer makes OVs a popular therapeutic tool. Today, both preclinical and early-stage clinical trials are intensively investigating the approach to improve oncolytic virotherapy. https://www.creative-biolabs.com/oncolytic-virus/applications-of-oncolytic-viruses-in-cancer-treatment.htm
Oncolytic Virus Application
Oncolytic Virus Application
Creative Biolabs
To fully optimize oncolytic virotherapy and provide meaningful mechanistic insight, it is important to have representative animal models of oncolysis in various tumor types. https://www.creative-biolabs.com/oncolytic-virus/animal-models-for-oncolytic-virus-study.htm
Oncolytic Virus Animal Model
Oncolytic Virus Animal Model
Creative Biolabs
Abciximab (also known as abcixifiban or c7E3 Fab), is the Fab fragment of the chimeric human-murine, monoclonal antibody 7E3. It is composed of murine variable regions and human constant regions.https://www.creativebiolabs.net/abciximab-overview.htm
Abciximab mechanism of action
Abciximab mechanism of action
Creative Biolabs
Abagovomab is a murine monoclonal anti-idiotypic antibody (MW: 165-175 kDa), produced by a mouse hybridoma and generated against OC125, which serves to functionally imitate the human cancer antigen 125 (CA-125). https://www.creativebiolabs.net/abagovomab-overview.htm
Abagovomab mechanism of action
Abagovomab mechanism of action
Creative Biolabs
Wnt comprises a diverse family of secreted lipid-modified signaling glycoproteins that are 350-400 amino acids in length. Wnt is an acronym in the field of genetics that stands for 'Wingless/Integrated'.https://www.creativebiolabs.net/wnt-signaling-pathway.htm
Wnt Pathway
Wnt Pathway
Creative Biolabs
TNF works through two receptors, TNFR1 and TNFR2. TNFR1 is the major signal receptor of TNF-α. TNFR2, which mediates limited biological responses, binds to TNF-α and TNF-β. TNF signaling transduction through TNFR1 and TNFR2 can induce a variety of cellular responses, which depends on many factors, including the metabolic state of the cell and the adaptor proteins present in the cell.https://www.creativebiolabs.net/tnf-signaling-pathway.htm
TNF Pathway
TNF Pathway
Creative Biolabs
Innate immune receptors, also known as pattern recognition receptors (PRRs), have been identified in the serum, on the cell surface, in endosomes, and in the cytoplasm. Toll-like receptors (TLRs) is one of the particularly important groups of PRRs.https://www.creativebiolabs.net/tlr-signal-pathway.htm
TLR Pathway
TLR Pathway
Creative Biolabs
Transforming growth factor beta (TGF-β) is a cytokine that participates in both physiological and pathological processes.https://www.creativebiolabs.net/tgf-beta-signaling-pathway.htm
TGF-β Pathway
TGF-β Pathway
Creative Biolabs
T-cell receptor (TCR) is a heterodimers composed of α and β peptide chains. TCR is mainly responsible for recognizing the antigens presented by major histocompatibility complex (MHC) molecules on the surface of antigen presenting cells (APC).https://www.creativebiolabs.net/tcr-signal-pathway.htm
TCR Pathway
TCR Pathway
Creative Biolabs
Ras, which is a low-molecular-weight GDP/GTP-binding guanine triphosphatase, is the prototypical member of the Ras superfamily of proteins. https://www.creativebiolabs.net/ras-signaling-pathway.htm
RAS Pathway
RAS Pathway
Creative Biolabs
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors, which are responsible for regulating gene expression.https://www.creativebiolabs.net/ppar-signaling-pathway.htm
PPAR Pathway
PPAR Pathway
Creative Biolabs
PI3K-Akt signaling pathway is one of the important signal transduction pathways in cells. It is involved in regulating cell metabolism, growth, proliferation, survival, transcription and protein synthesis by affecting the activation of downstream effector molecules. https://www.creativebiolabs.net/pi3k-akt-signaling-pathway.htm
VPI3K-AKT Pathway
VPI3K-AKT Pathway
Creative Biolabs
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD19. https://www.creativebiolabs.net/anti-cd19-adcc-enhanced-antibody-taplitumomab-105903.htm
Afuco™ Anti-CD19 ADCC Recombinant Antibody (Taplitumomab), ADCC Enhanced
Afuco™ Anti-CD19 ADCC Recombinant Antibody (Taplitumomab), ADCC Enhanced
Creative Biolabs
Recombinant chimeric antibody expressed in CHO binding to human CAIX. Girentuximab is a chimeric monoclonal antibody designed for the treatment of renal cell carcinoma. https://www.creativebiolabs.net/Anti-CAIX-CA9-Therapeutic-Antibody-Rencarex-13758.htm
Anti-CAIX/CA9 Recombinant Antibody
Anti-CAIX/CA9 Recombinant Antibody
Creative Biolabs
Recombinant mouse monoclonal antibody expressed in CHO binding to human B-lymphoma cell. Detumomab is a mouse monoclonal antibody developed for the treatment of cancer. https://www.creativebiolabs.net/Anti-B-cell-lymphomas-Therapeutic-Antibody-detumomab-326.htm
Anti-B Cell Lymphomas Recombinant Antibody
Anti-B Cell Lymphomas Recombinant Antibody
Creative Biolabs
Recombinant monoclonal antibody to P. aeruginosa. Panobacumab (proposed INN) is a monoclonal antibody designed as an antibacterial against P. aeruginosa. It is a fully human pentameric IgM antibody with a mouse J chain. https://www.creativebiolabs.net/Anti-B-anthracis-anthrax-protective-antigen-PA-Therapeutic-Antibody-Aerumab-11-13641.htm
Anti-B. anthracis anthrax protective antigen
Anti-B. anthracis anthrax protective antigen
Creative Biolabs
Recombinant monoclonal antibody to Bacillus anthracis protective antigen. Raxibacumab is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax. Its efficacy has been proven in rabbits and monkeys. https://www.creativebiolabs.net/Anti-B-anthracis-anthrax-protective-antigen-PA-Therapeutic-Antibody-ABthrax-13697.htm
Anti-B. Anthracis Anthrax Protective Antigen (Raxibacumab)
Anti-B. Anthracis Anthrax Protective Antigen (Raxibacumab)
Creative Biolabs
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human AFP. Tacatuzumab is a humanized monoclonal antibody intended for the treatment of cancer. https://www.creativebiolabs.net/anti-afp-adcc-enhanced-antibody-tacatuzumab-105879.htm
Afuco™ Anti-AFP ADCC Recombinant Antibody (Tacatuzumab), ADCC Enhanced
Afuco™ Anti-AFP ADCC Recombinant Antibody (Tacatuzumab), ADCC Enhanced
Creative Biolabs
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to CD22. https://www.creativebiolabs.net/anti-cd22-adcc-enhanced-antibody-inotuzumab-105908.htm
Afuco™ Anti-CD22 ADCC Recombinant Antibody (Inotuzumab), ADCC Enhanced
Afuco™ Anti-CD22 ADCC Recombinant Antibody (Inotuzumab), ADCC Enhanced
Creative Biolabs
Recombinant monoclonal antibody to MMP9. Andecaliximab is a human monoclonal antibody that can be potentially used in the treatment of Crohn's disease (CD), Colitis, ulcerative (UC), Solid tumors. https://www.creativebiolabs.net/Andecaliximab-67638.htm
Anti-Human MMP9 Recombinant Antibody
Anti-Human MMP9 Recombinant Antibody
Creative Biolabs
Mehr von Creative Biolabs
(20)
Oncolytic Virus Application
Oncolytic Virus Application
Oncolytic Virus Animal Model
Oncolytic Virus Animal Model
Abciximab mechanism of action
Abciximab mechanism of action
Abagovomab mechanism of action
Abagovomab mechanism of action
Wnt Pathway
Wnt Pathway
TNF Pathway
TNF Pathway
TLR Pathway
TLR Pathway
TGF-β Pathway
TGF-β Pathway
TCR Pathway
TCR Pathway
RAS Pathway
RAS Pathway
PPAR Pathway
PPAR Pathway
VPI3K-AKT Pathway
VPI3K-AKT Pathway
Afuco™ Anti-CD19 ADCC Recombinant Antibody (Taplitumomab), ADCC Enhanced
Afuco™ Anti-CD19 ADCC Recombinant Antibody (Taplitumomab), ADCC Enhanced
Anti-CAIX/CA9 Recombinant Antibody
Anti-CAIX/CA9 Recombinant Antibody
Anti-B Cell Lymphomas Recombinant Antibody
Anti-B Cell Lymphomas Recombinant Antibody
Anti-B. anthracis anthrax protective antigen
Anti-B. anthracis anthrax protective antigen
Anti-B. Anthracis Anthrax Protective Antigen (Raxibacumab)
Anti-B. Anthracis Anthrax Protective Antigen (Raxibacumab)
Afuco™ Anti-AFP ADCC Recombinant Antibody (Tacatuzumab), ADCC Enhanced
Afuco™ Anti-AFP ADCC Recombinant Antibody (Tacatuzumab), ADCC Enhanced
Afuco™ Anti-CD22 ADCC Recombinant Antibody (Inotuzumab), ADCC Enhanced
Afuco™ Anti-CD22 ADCC Recombinant Antibody (Inotuzumab), ADCC Enhanced
Anti-Human MMP9 Recombinant Antibody
Anti-Human MMP9 Recombinant Antibody
Jetzt herunterladen